Intra-cerebral cannabidiol infusion-induced neuroprotection is partly associated with the TNF-α/TNFR1/NF-кB pathway in transient focal cerebral ischaemia

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Brain Injury

• Publication date

  2017-09-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/02699052.2017.1358397PMID 28872345
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review

  2015cited by this paper
• The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells.

  2015cited by this paper
• PACAP38 Differentially Effects Genes and CRMP2 Protein Expression in Ischemic Core and Penumbra Regions of Permanent Middle Cerebral Artery Occlusion Model Mice Brain

  2014cited by this paper
• The role of potassium BK channels in anticonvulsant effect of cannabidiol in pentylenetetrazole and maximal electroshock models of seizure in mice.

  2013cited by this paper
• Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function.

  2012influential reference
• Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol

  2011cited by this paper
• Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.

  2011cited by this paper
• Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement

  2011cited by this paper
• The neuroprotective effect of olive leaf extract is related to improved blood-brain barrier permeability and brain edema in rat with experimental focal cerebral ischemia.

  2011cited by this paper
• The role of tumor necrosis factor-alpha and TNF-alpha receptors in cerebral arteries following cerebral ischemia in rat

  2011cited by this paper
• The role of tumor necrosis factor-α and TNF-α receptors in cerebral arteries following cerebral ischemia in rat

  2011cited by this paper
• Cannabidiol Reduces Brain Damage and Improves Functional Recovery After Acute Hypoxia-Ischemia in Newborn Pigs

  2011cited by this paper
• The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors.

  2010influential reference
• Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ Levels

  2009cited by this paper
• Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders

  2009cited by this paper
• NF-kappaB signaling in cerebral ischemia.

  2009cited by this paper
• Inhibition of Human Neutrophil Chemotaxis by Endogenous Cannabinoids and Phytocannabinoids: Evidence for a Site Distinct from CB1 and CB2

  2008cited by this paper
• Neuroprotective Effects of the Nonpsychoactive Cannabinoid Cannabidiol in Hypoxic-Ischemic Newborn Piglets

  2008cited by this paper
• Cell adhesion molecules and ischemic stroke

  2008cited by this paper
• Dimethyl sulfoxide provides neuroprotection in a traumatic brain injury model

  2008cited by this paper
• Stroke.

  2008cited by this paper
• Prolonged and intermittent normobaric hyperoxia induce different degrees of ischemic tolerance in rat brain tissue.

  2007cited by this paper
• Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor‐independent myeloperoxidase‐inhibiting mechanism

  2007cited by this paper
• Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression.

  2007cited by this paper
• Cannabidiol in vivo blunts β‐amyloid induced neuroinflammation by suppressing IL‐1β and iNOS expression

  2007cited by this paper
• Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance.

  2007cited by this paper
• Journal of Translational Medicine BioMed Central

  2007cited by this paper
• Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications.

  2007cited by this paper
• Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement.

  2006influential reference
• Microglia Potentiate Damage to Blood–Brain Barrier Constituents: Improvement by Minocycline In Vivo and In Vitro

  2006cited by this paper
• Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.

  2005cited by this paper
• Cannabidiol Prevents Cerebral Infarction Via a Serotonergic 5-Hydroxytryptamine1A Receptor–Dependent Mechanism

  2005cited by this paper
• Tumor Necrosis Factor-α Neutralization Reduced Cerebral Edema Through Inhibition of Matrix Metalloproteinase Production After Transient Focal Cerebral Ischemia

  2005cited by this paper
• Mitochondrial respiratory chain and free radical generation in stroke.

  2005cited by this paper
• Immature rat brain slices exposed to oxygen-glucose deprivation as an in vitro model of neonatal hypoxic-ischemic encephalopathy.

  2005cited by this paper
• Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia.

  2005cited by this paper
• Neuroprotective effect of cannabidiol, a non‐psychoactive component from Cannabis sativa, on β‐amyloid‐induced toxicity in PC12 cells

  2004cited by this paper
• Regulation of proliferation, survival and apoptosis by members of the TNF superfamily.

  2003cited by this paper
• Tumor necrosis factor signaling

  2003cited by this paper
• Cerebral impedance and neurological outcome following a mild or severe hypoxic/ischemic episode in neonatal piglets.

  2003cited by this paper
• Examination of sensorimotor performance following middle cerebral artery occlusion in rats.

  2003cited by this paper
• Post-ischemic treatment with cannabidiol prevents electroencephalographic flattening, hyperlocomotion and neuronal injury in gerbils.

  2003cited by this paper
• Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential

  2002cited by this paper
• Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential

  2002cited by this paper
• High glucose induced nuclear factor kappa B mediated inhibition of endothelial cell migration.

  2002cited by this paper
• Marijuana and Cannabinoids

  2001cited by this paper
• Pathobiology of ischaemic stroke: an integrated view.

  1999cited by this paper
• Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.

  1998cited by this paper
• Expression of TNF and TNF Receptors (p55 and p75) in the Rat Brain after Focal Cerebral Ischemia

  1997cited by this paper
• Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis

  1996cited by this paper
• Extracellular neurotransmitter changes in cerebral ischaemia.

  1995cited by this paper
• Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets.

  1992cited by this paper
• A Semiautomated Method for Measuring Brain Infarct Volume

  1990cited by this paper
• Reversible middle cerebral artery occlusion without craniectomy in rats.

  1989cited by this paper
• Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes.

  1987cited by this paper
• AChE-stained horizontal sections of the rat brain in stereotaxic coordinates.

  1980cited by this paper
• Nuclear Factor- (cid:1) B Contributes to Infarction After Permanent Focal Ischemia

  year unknowncited by this paper

• Exploring the neuroprotective effects and underlying mechanisms of medical cannabinoids in ischemic stroke: a systematic meta-analysis with bibliometric mapping of cerebral ischemia research

  2026cites this paper
• Unlocking the potential: Cannabidiol (CBD) as a promising anti-tumor agent.

  2025cites this paper
• Antitumor effects of cannabidiol (CBD) on osteosarcoma by targeting TNF-α/NF-κB/CCL5 signaling axis.

  2025cites this paper
• Cannabidiol Modulates Neuroinflammatory and Estrogen-Related Pathways in a Sex-Specific Manner in a Chronic Stress Model of Depression

  2025cites this paper
• The intervention mechanism of Tanshinone IIA in alleviating neuronal injury induced by HMGB1 or TNF-α-mediated microglial activation.

  2024cites this paper
• Cannabidiol (CBD) modulates the transcriptional profile of ethanol-exposed human dermal fibroblast cells

  2024cites this paper
• Antibiofilm and Immune-Modulatory Activity of Cannabidiol and Cannabigerol in Oral Environments—In Vitro Study

  2024cites this paper
• BAO-Ag-NPs as Promising Suppressor of ET-1/ICAM-1/VCAM-1 Signaling Pathway in ISO-induced AMI in Rats.

  2023cites this paper
• Cannabidiol goes nuclear: The role of PPARγ.

  2023cites this paper
• Qinzhi Zhudan formula improves memory and alleviates neuroinflammation in vascular dementia rats partly by inhibiting the TNFR1-mediated TNF pathway

  2022cites this paper
• Cannabidiol Exerts a Neuroprotective and Glia-Balancing Effect in the Subacute Phase of Stroke

  2022cites this paper
• Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges

  2022cites this paper
• Systemic immune responses after ischemic stroke: From the center to the periphery

  2022cites this paper
• Cannabidiol Reduces Short- and Long-Term High Glutamate Release after Severe Traumatic Brain Injury and Improves Functional Recovery

  2022cites this paper
• Antioxidant and Anti-apoptotic Effects of Cannabidiol in Model of Ischemic Stroke in Rats.

  2022cites this paper
• Blood-Brain Barrier Mechanisms in Stroke and Trauma.

  2021cites this paper
• Effects of Cannabidiol and Beta-Caryophyllene Alone or in Combination in a Mouse Model of Permanent Ischemia

  2021cites this paper
• Neuroprotective Phytochemicals in Experimental Ischemic Stroke: Mechanisms and Potential Clinical Applications

  2021cites this paper
• Neuroprotective Effects of Cannabidiol Under Cerebral Ischemic Conditions

  2021cites this paper
• Selective Targeting of TNF Receptors as a Novel Therapeutic Approach

  2020cites this paper
• A Network Pharmacology–Based Analysis of the Protective Mechanism of Miao Medicine Xuemaitong Capsule Against Secondary Brain Damage in the Ischemic Area Surrounding Intracerebral Hemorrhage

  2020cites this paper
• Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders

  2020cites this paper
• Immune Responses Regulated by Cannabidiol

  2020cites this paper
• Modeling poststroke epilepsy and preclinical development of drugs for poststroke epilepsy.

  2020cites this paper
• Cannabidiol alleviates hemorrhagic shock‐induced neural apoptosis in rats by inducing autophagy through activation of the PI3K/AKT pathway

  2020cites this paper
• The Role of Selected Pro-Inflammatory Cytokines in Pathogenesis of Ischemic Stroke

  2020cites this paper
• CIA_A_233909 469..484

  2020cites this paper
• Cannabis sativa L . extract and cannabidiol differently inhibit in vitro mediators of skin inflammation and wound injury

  2019cites this paper
• Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain

  2019cites this paper
• Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology

  2019cites this paper
• Variability in daily self-reported emotional symptoms and fatigue measured over eight weeks in community dwelling individuals with traumatic brain injury

  2019cites this paper
• Multi-parametric analysis reveals metabolic and vascular effects driving differences in BOLD-based cerebrovascular reactivity associated with a history of sport concussion

  2019cites this paper
• Detection of intracranial hematomas in the emergency department using near infrared spectroscopy

  2019cites this paper
• Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury

  2019cites this paper
• Single tDCS session of motor cortex in patients with disorders of consciousness: a pilot study

  2019cites this paper
• Technology and TBI: Perspectives of persons with TBI and their family caregivers on technology solutions to address health, wellness, and safety concerns

  2019cites this paper
• Assessment of memory functioning over two years following severe childhood traumatic brain injury: results of the TGE cohort

  2019cites this paper
• Dynamic protein expression of NF-κB following rat intracerebral hemorrhage and its association with apoptosis

  2018cites this paper
• Goal management training ® home-based approach for mild cognitive impairment in Parkinson’s disease: a multiple baseline case report

  2018cites this paper
• Treatment of social cognition impairments in patients with traumatic brain injury: a critical review

  2018cites this paper
• In their own words: developing the Parent Experiences Questionnaire following neonatal brain injury using participatory design

  2018cites this paper
• Key Aspects to Consider about Beneficial and Harmful Effects on the Central Nervous System by the Endocannabinoid Modulation Linked to New Cardiovascular Therapies

  2016cites this paper
• The Role of Selected Pro-In fl ammatory Cytokines in Pathogenesis of Ischemic Stroke

  year unknowncites this paper
• EngagedScholarship@CSU EngagedScholarship@CSU

  year unknowninfluential citation